ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,476 Cr | ₹5,902 Cr | ₹5,178 Cr | ₹4,539 Cr | ₹4,207 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹6,476 Cr |
| Mar2025 | ₹5,902 Cr |
| Mar2024 | ₹5,178 Cr |
| Mar2023 | ₹4,539 Cr |
| Mar2022 | ₹4,207 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,476 Cr | 9.72 | |
| Mar2025 | ₹5,902 Cr | 14.00 | |
| Mar2024 | ₹5,178 Cr | 14.08 | |
| Mar2023 | ₹4,539 Cr | 7.88 | |
| Mar2022 | ₹4,207 Cr | - | |
Compare Total Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,902.5 Cr | -0.1% | 8% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.1% |
8% |
-20.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses